Zelda Therapeutics Ltd (ASX: ZLD has announced it has secured regulatory approval to conduct a clinical trial of its cannabis medicines with chronic insomnia patients in Australia. The trial is expected to commence in the first quarter of next year and patient recruitment should begin shortly. Read More
The post Australian First Medical Cannabis Trial For Insomnia appeared first on Dagga Magazine.